SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider, today announced the launch of SpectraMax® iD5e and SpectraMax® iD3s Multi-Mode Microplate Readers. Honoring a legacy of product line reliability and strength, the SpectraMax Multi-Mode Microplate Readers have been transformed with next-generation innovation to improve research capabilities and provide unparalleled flexibility […]
WOBURN, Mass. — Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership significantly expands global access to Spear Bio’s groundbreaking SPEAR UltraDetect™ immunoassays, […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio’s next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne will distribute Spear Bio’s ultrasensitive immunoassays for challenging low-abundance biomarkers, including key Alzheimer’s disease biomarkers such as phosphorylated tau 217 (pTau 217), GFAP, neurofilament light […]
The new kit combines Vector’s validated lectins with Navinci’s in situ PLA technology to gain insights beyond protein expression NEWARK, Calif. — Vector Laboratories, a leader in innovative proteomic and glycomic research solutions, and Navinci, an established developer of in situ proximity ligation assay-based solutions, today announced the launch of the Glysite™ Explorer in situ PLA Glycan Detection Kit. The […]
Promega Plasmid Collection, available through Addgene, equips industry and academic researchers with powerful bioluminescent assays that provide deeper insights into endogenous cellular biology Watertown, MA USA. — Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility, today announced a strategic partnership with Promega to expand Addgene’s vast plasmid repository with the launch […]
n6™ Announces Strategic Partnership with SeqCenter to Deliver Unmatched Data Quality in Metagenomics
MILAN — n6 is proud to announce a strategic partnership with SeqCenter, who is launching a groundbreaking full-length 16S sequencing service at FEMS Micro. This collaboration leverages n6’s iconPCR™ technology to empower researchers with superior data quality, reproducibility, and streamlined workflows, making advanced microbiome research accessible to all. n6 is excited to support SeqCenter in setting a new […]
MADISON, Wis. — BrainXell, Inc., a leading biotechnology company developing iPSC-based CNS disease models and regenerative cell therapies, announces the appointment of Katherine Vega Stultz as its new Chief Executive Officer and Board Director. Ms. Stultz is a veteran biotech executive with more than two decades of experience advancing therapeutics across modalities and diseases. She brings decades of leadership […]
Browse AAA Biotech’s new range of validated antibodies, ELISA kits, and culture media – empowering researchers with high-quality, reliable research reagents. LA JOLLA, CA, UNITED STATES — AAA Biotech, a leader in providing validated research reagents, announces the launch of its suite of validated antibodies, ELISA kits, and culture media. The company reaffirms its commitment to empowering […]
New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results CARLSBAD, Calif. — Today, Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* helping accelerate precision oncology research. The Oncomine Comprehensive Assay Plus detects a broad range of […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
